{
    "applicationNumber": "BR 11 2023 000687-2",
    "filingDate": "15/07/2021",
    "grantDate": null,
    "title": "M\u00c9TODOS E COMBINA\u00c7\u00d5ES DE INIBIDORES DE KAT6 PARA O TRATAMENTO DE C\u00c2NCER",
    "nationalPhaseDate": [
        "13/01/2023"
    ],
    "internationalApplication": {
        "pctNumber": "PCT EP2021/069787",
        "pctDate": "15/07/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "63/052,215",
            "priorityDate": "15/07/2020"
        },
        {
            "countryCode": "US",
            "priorityNumber": "63/211,044",
            "priorityDate": "16/06/2021"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2716"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2718"
        },
        {
            "code": "25.7",
            "description": "Altera\u00e7\u00e3o de Sede Deferida",
            "bulletinNumber ": "2742"
        }
    ],
    "inventors": [
        "PAUL ANTHONY STUPPLE",
        "ANTHONY MAZUREK",
        "KIM TIMOTHY ARNDT",
        "LEI CHEN",
        "MAXIMILLIAN TODD FOLLETTIE",
        "DAVID SCOTT FRUHLING",
        "PEI KUNG",
        "WENYAN ZHONG",
        "PHILIP MICHAEL TEDESCHI"
    ],
    "holders": [
        334896,
        93871
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 31/519",
        "A61K 31/18",
        "A61K 31/506",
        "A61K 31/423",
        "A61K 31/565",
        "A61K 31/4196",
        "A61K 45/06",
        "A61K 31/7064"
    ]
}